Curaleaf Holdings (CURLF) Other Non Operating Income (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Other Non Operating Income of -$4.1 million for Q1 2026, down 235.43% year-over-year from $3.0 million in Q1 2025, and down 234.8% quarter-over-quarter from $3.0 million in Q4 2025.
Curaleaf Holdings (CURLF) Other Non Operating Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Other Non Operating Income history runs 8 years deep, the most recent figure standing at -$4.1 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 235.43% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at -$1.5 million (down 106.97% YoY), while the FY2025 annual figure was $5.6 million, down 65.08% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$4.1 million, down from $3.0 million in the prior quarter.
- The five-year high for Other Non Operating Income was $18.5 million in Q2 2022, with the low at -$4.1 million in Q1 2026.
- The 5-year median for Other Non Operating Income is $1.8 million (2025), against an average of $2.4 million.
- Peak annual rise in Other Non Operating Income reached 402.11% in 2024, while the deepest fall reached 383.16% in 2024.
- Curaleaf Holdings' Other Non Operating Income stood at $2.7 million in 2022, then tumbled by 245.47% to -$3.9 million in 2023, then soared by 402.11% to $11.7 million in 2024, then slumped by 74.29% to $3.0 million in 2025, then plunged by 234.8% to -$4.1 million in 2026.
- Business Quant data shows CURLF's Other Non Operating Income at -$4.1 million in Q1 2026, $3.0 million in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Curaleaf Holdings | 2.50 Bn | 2.40 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.92 Mn |
| Mar 31, 2026 | -4.07 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 11.73 Mn |
| Sep 30, 2024 | 4.73 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -3.88 Mn |
| Sep 30, 2023 | -2.80 Mn |
| Jun 30, 2023 | 7.36 Mn |
| Mar 31, 2023 | -487,000.00 |
| Dec 31, 2022 | 2.67 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 18.46 Mn |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | -22.31 Mn |
| Sep 30, 2021 | -13.90 Mn |